Camila Braganca Xavier (@camilabragancax) 's Twitter Profile
Camila Braganca Xavier

@camilabragancax

Investigational Cancer Therapeutics Clinical Fellow @MDAndersonNews | Focused on GI malignancies | Committee services MDA GME HSS @ASCO 🇺🇸@SBOC_Oncologia 🇧🇷

ID: 1154433070960906240

calendar_today25-07-2019 16:47:47

336 Tweet

1,1K Followers

1,1K Following

Camila Braganca Xavier (@camilabragancax) 's Twitter Profile Photo

Is it a good idea to take antihistamines or PPIs while enrolled in an early-phase #immunotherapy #clinicaltrials? How can it change treatment outcomes of monoclonal antibodies, immunomodulators, oncolytic viruses, and vaccines? Check today at #AACR25 MD Anderson Cancer Center

Is it a good idea to take antihistamines or PPIs while enrolled in an early-phase #immunotherapy #clinicaltrials? How can it change treatment outcomes of monoclonal antibodies, immunomodulators, oncolytic viruses, and vaccines? Check today at #AACR25 <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>
Camila Braganca Xavier (@camilabragancax) 's Twitter Profile Photo

Paper 2/2 of our pilot prediction model to determine survival probability on #immunotherapy I would like to highlight the potential importance of the HLA-A point mutations in a neoantigen-restricted scenario (TMB-low cohort) MD Anderson Cancer Center Princess Margaret Cancer Centre doi.org/10.1093/oncolo…

Paper 2/2 of our pilot prediction model to determine survival probability on #immunotherapy I would like to highlight the potential importance of the HLA-A point mutations in a neoantigen-restricted scenario (TMB-low cohort) <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> <a href="/pmcancercentre/">Princess Margaret Cancer Centre</a> doi.org/10.1093/oncolo…
Thais Megid (@megidthais) 's Twitter Profile Photo

💊 Can DFS be used as a surrogate for OS in early-stage pancreatic cancer trials? 📈 In a meta-analysis of 29 RCTs (n=6777), DFS strongly correlated with OS (R=0.70 adjuvant | R=0.90 neoadjuvant). 📍 DFS may be a reliable surrogate endpoint for OS. bmjoncology.bmj.com/content/bmjonc…

💊 Can DFS be used as a surrogate for OS in early-stage pancreatic cancer trials?
📈 In a meta-analysis of 29 RCTs (n=6777), DFS strongly correlated with OS (R=0.70 adjuvant | R=0.90 neoadjuvant).
📍 DFS may be a reliable surrogate endpoint for OS.
bmjoncology.bmj.com/content/bmjonc…
Heloisa Soares MD (@helops79) 's Twitter Profile Photo

Big news for the #NETs community! ASCO has released its first guideline to help oncologists manage symptoms of GEP NETS. A major step forward in improving quality of life of patients. dailynews.ascopubs.org/do/asco-releas… congrats Jaydira Del Rivero, MD and all!

Goutham Sunny (@medoncodoc) 's Twitter Profile Photo

💥NORDIC NEC 2 💥 📢 New prospective multicenter study on digestive high-grade neuroendocrine neoplasms (HG-NEN) 💡 🧬 Subtypes: NEC vs NET G3 👥 n=544 (NEC: 427, NET G3: 117) 💊 Palliative chemo outcomes: 📉 Immediate progression: •NEC: 41% •NET G3: 24% 📊 Median PFS:

💥NORDIC NEC 2 💥

📢 New prospective multicenter study on digestive high-grade neuroendocrine neoplasms (HG-NEN) 💡

🧬 Subtypes: NEC vs NET G3
👥 n=544 (NEC: 427, NET G3: 117)
💊 Palliative chemo outcomes:

📉 Immediate progression:
•NEC: 41%
•NET G3: 24%

📊 Median PFS:
Camila Braganca Xavier (@camilabragancax) 's Twitter Profile Photo

I had a great time today seeing beyond the satires of Dr. Glaucomflecken — what a a beautiful lesson of resilience! And, as always, had a blast w/ the living legends that push the bar to make cancer history! MD Anderson Cancer Center Carlos Torrado

Renee Maria Saliby (@reneesaliby) 's Twitter Profile Photo

It's #ASCO25 week! - Use the ASCO app to plan your meeting - Don't forget the "non-traditional" sessions (1:1 mentorship, #SoMe...) Join us at the Mentorship 101 session (details in picture) OncoAlert

It's #ASCO25 week! 
- Use the ASCO app to plan your meeting
- Don't forget the "non-traditional" sessions (1:1 mentorship, #SoMe...)

Join us at the Mentorship 101 session (details in picture)

<a href="/OncoAlert/">OncoAlert</a>
Camila Braganca Xavier (@camilabragancax) 's Twitter Profile Photo

Beyond happy to join G Curigliano MD PhD, Narjust Florez, MD, FASCO & Renee Maria Saliby for an interactive talk on mentorship at the Trainee & Early Career Lounge. I can’t imagine building up my career without the support of many formal & informal mentors I’ve had along the way! #ASCO25 MD Anderson Cancer Center

Beyond happy to join <a href="/curijoey/">G Curigliano MD PhD</a>, <a href="/NarjustFlorezMD/">Narjust Florez, MD, FASCO</a> &amp; <a href="/ReneeSaliby/">Renee Maria Saliby</a> for an interactive talk on mentorship at the Trainee &amp; Early Career Lounge. I can’t imagine building up my career without the support of many formal &amp; informal mentors I’ve had along the way! #ASCO25 <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>
Daniel Haldar (@danielhaldarmd) 's Twitter Profile Photo

Huge week for GI Medical Oncology MD Anderson Cancer Center with not one - but TWO - NEJM articles published by our group. Perfect start to #ASCO25! 1️⃣ Beautiful review on the unique biology and treatment of cancer of unknown primary (CUP) authored by our own Dr. Kanwal Raghav 🩺 🖖🏻

David S. Hong MD (@davidhongmd) 's Twitter Profile Photo

Nothing better than seeing your fellows and mentees presenting and succeeding! Congrats Dr Lim, Dr Xavier, Dr Fox!@MDAndersonNews

Nothing better than seeing your fellows and mentees presenting and succeeding! Congrats Dr Lim, Dr Xavier, Dr Fox!@MDAndersonNews
Camila Braganca Xavier (@camilabragancax) 's Twitter Profile Photo

Our lovely pic w/ the amazing MD Anderson Cancer Center ICT APPs ⭐️ Thank you for your friendship & support during our Fellowship. I will miss you all incredibly — luckily we will be only 2 floors away! Mohamed A Gouda Carlos Torrado

#TumorBoardTuesday (@tumorboardtues) 's Twitter Profile Photo

#TumorBoardTuesday 😮We had a rare #ASCO25 with several key🗝️updates in #PancreaticCancer So to put this in context: 📢Join us Tuesday, 07-08-25 at 8PM ET as Dr. Shubham Pant & Daniel Haldar 🗣️Optimizing 1L Treatment Selection in mPDAC RT and bring others into the discussion‼️

#TumorBoardTuesday

😮We had a rare #ASCO25 with several key🗝️updates in #PancreaticCancer
So to put this in context:
📢Join us Tuesday, 07-08-25 at 8PM ET as <a href="/DrShubhamPant/">Dr. Shubham Pant</a> &amp; <a href="/DanielHaldarMD/">Daniel Haldar</a> 🗣️Optimizing 1L Treatment Selection in mPDAC

RT and bring others into the discussion‼️